Sienna Biopharmaceuticals is likely to close within the next week and lay off its remaining employees as it files with the Securities and Exchange Commission for the delisting of all of its securities. Multiple news outlets, including Bankrupt Company News and Becker’s Hospital Review, reported the latest developments for the Westlake Village-based company after it…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
